The efficacy of immunomodulators for the treatment of vitiligo is supported by results from a literature review published in Dermatologic Therapy. In a systematic review, investigators explored the current data for vitiligo therapy, concluding that immunomodulators and other emerging treatment modalities may become more prominent in coming years.

Investigators conducted a search of the PubMed, SCOPUS, EMBASE, MEDLINE, and Cochrane databases for English-language publications describing vitiligo treatment. Special emphasis was placed on identifying articles describing immunomodulators—a relatively new therapeutic option.